Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
Step by step instructions to Figure out the Natural Effect of 5G Pinnacles- Radiated Tortoise Faces Rapid Decline in Madagascar
- IDF says up to 90% of Iran’s weapons industry could be hit within days
- How to Build a Yard That Helps Monarchs During Spring Migration
- Early Thanksgiving week forecast: Where Americans can expect cold, rain and snow for the holiday
- The most effective method to Promoter for Cutthroat Medical attendant Compensations in Your Medical services Office
- What Middle East Conflict Could Mean For The World’s Largest Whale Shark Gathering
- Astronauts on the ISS watched NASA's historic Artemis 2 launch from space
- Soldiers seize power in Guinea-Bissau and detain the president
